- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-17-0281888

Rikul Pharmaceuticals Private Limited
About Rikul Pharmaceuticals Private Limited
Data last updated:
Rikul Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 November 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U33100WB2022PTC257980.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Mukul Sanganeria and Rithik Sanganeria.
Its last annual general meeting (AGM) was held on 15 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 5C Block A Bhawani Tower Samarpally Barwaritalla More, Kolkata, West Bengal, India – 700102.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.74 Cr. For the same year it recorded a net loss of ₹86.5 Lakh (net margin -49.8%) and EBITDA of -₹22.29 Lakh (EBITDA margin -12.8%).
As per MCA filings, the company has open charges of ₹3.2 Cr on record.
Rikul Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0281888). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Rikul Pharmaceuticals
Contact details
Rikul Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal.
- Registered AddressFlat No. 5C Block A Bhawani Tower Samarpally Barwaritalla More, Kolkata, West Bengal, India – 700102
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rikul Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Rikul Pharmaceuticals Private Limited, buy the company report.
Financials of Rikul Pharmaceuticals Private Limited
FY 2025 filings availableRikul Pharmaceuticals Private Limited reported revenue of ₹1.74 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹22.29 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹86.5 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -12.8% | ||
| Net Profit Margin | -49.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Rikul Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rikul Pharmaceuticals Private Limited
Rikul Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukul Sanganeria | Director | 01 Nov 2022 | 4 Years 0 Months | Current |
| Rithik Sanganeria | Director | 01 Nov 2022 | 4 Years 0 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Jun 2023 | 100745740 | Others | ₹3.2 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Rikul Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rikul Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rikul Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rikul Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Mukul Sanganeria was appointed as Director on 01 Nov 2022.
Frequently asked questions
Rikul Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 November 2022 (4+ years old) and is registered under CIN U33100WB2022PTC257980.
Rikul Pharmaceuticals has 2 current directors:
- Mukul Sanganeria - Director
- Rithik Sanganeria - Director
The latest financial statements of Rikul Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 July 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Rikul Pharmaceuticals is U33100WB2022PTC257980. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rikul Pharmaceuticals was incorporated on 01 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
Mukul Sanganeria was appointed as Director on 01 Nov 2022. Rithik Sanganeria was appointed as Director on 01 Nov 2022.
Yes, Rikul Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0281888).
The registered office of Rikul Pharmaceuticals is at Flat No. 5C Block A Bhawani Tower Samarpally Barwaritalla More, Kolkata, West Bengal, India – 700102.
Rikul Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Rikul Pharmaceuticals has open charges of ₹3.2 Cr and no satisfied charges on record as per latest MCA filings.

